Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis.

Crit Care Explor · 2023 · PMC10635596 · PMID 37954898

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Findings: Human genetic cohort studies demonstrated a nonsignificant trend toward improved survival among carriers of PCSK9 loss-of-function genetic variants.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.